Life sciences company Thermo Fisher (NYSE:TMO) will be reporting earnings tomorrow before the bell. Here’s what to expect. Thermo Fisher beat analysts’ revenue expectations by 1% last quarter ...

Thermo Fisher has outlaid $2bn to expand manufacturing and development in the US, joining the long list of companies directing resources to domestic operations as ongoing US tariffs risk ...

Thermo Fisher's updated 2025 guidance shows a $1 EPS, or 4.2% hit from tariffs and government spending cuts. Thermo can mitigate the tariff issues by next year, as its scale gives it options to ...

Three-quarters of the pledge will bolster Thermo Fisher’s manufacturing operations, while the remaining $500 million will expand its R&D efforts. “Thermo Fisher’s commitment to U.S ...

Thermo Fisher Scientific received site plan approval from the Pease Development Authority to build a new aircraft hangar and office at the Pease International Tradeport. The project includes a two ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will invest an additional $2 billion in the United States over the next four years ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, is employing an enhanced platform technology and a new CHO K-1 cell line that can reduce timelines ...

Thermo Fisher CEO Marc Casper noted strong performance in Q1 2025, delivering $10.36 billion in revenue. Adjusted EPS grew 1% to $5.15. Adjusted operating income was $2.27 billion, with an ...

Thermo Fisher Scientific Inc. (TMO), a prominent player in the Life Sciences Tools & Services industry with a market capitalization of $171.5 billion, reported its earnings for the first quarter ...

Thermo Fisher Scientific announced a $2 billion investment in US operations over the next four years to bolster domestic innovation and manufacturing capabilities in the life sciences sector.

In this article, we are going to take a look at where Thermo Fisher Scientific Inc. (NYSE:TMO) stands against Richard Chilton’s other stock picks. Richard Chilton is a veteran investor and the ...

A congressional transaction is when any representative or senator either buys or sells an individual stock. Anyone working in Congress must file a Periodic Transaction Report to inform the public ...